HSChapter 90
U.S. imports of ozone, oxygen & aerosol therapy and artificial respiration apparatus (HS 901920) totaled $370.1M in April 2026, traded with 47 countries.
Importers of Ozone, Oxygen & Aerosol Therapy and Artificial Respiration Apparatus paid $5.9M in duties in April 2026 — an effective duty rate of 9.8% on $59.7M in dutiable value, based on actual customs collections rather than the published tariff schedule.
Last updated: April 2026 dataRespiratory therapy equipment — including oxygen concentrators, CPAP/BiPAP devices, aerosol nebulizers, and artificial respiration apparatus — falls under this heading and is subject to FDA medical device regulation, with many life-sustaining devices requiring 510(k) clearance or premarket approval before US distribution. Singapore leads US imports under this heading, a reflection of the significant medical-device manufacturing base established there by multinational OEMs, with China and Mexico also supplying meaningful volumes. The heading consolidates into a single 10-digit tariff line (9019200000), so the classification question is typically whether a device performs therapeutic respiration versus merely delivering gas (which may fall elsewhere in Chapter 90 or under Chapter 84).
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
The key distinction is therapeutic function: apparatus designed to treat a medical condition through ozone, oxygen, aerosol, or artificial respiration belongs here, while equipment that merely supplies or measures gas flow (e.g., industrial oxygen regulators) typically falls under Chapter 84 or other Chapter 90 headings. CBP binding rulings and the Explanatory Notes to heading 9019 are the primary reference points; a licensed customs broker can help assess borderline devices.
CPAP and BiPAP devices are Class II medical devices regulated by FDA's CDRH and generally require 510(k) premarket notification clearance. The foreign manufacturer must be registered with FDA and the device listed before importation. FDA may detain shipments at the port of entry if clearance documentation is not in order. Importers should work with a regulatory affairs specialist to confirm device classification and clearance status prior to shipment.
Monthly import values over time
Supplier Network
Get discovered by U.S. importers searching for HS 901920 — Ozone, Oxygen & Aerosol Therapy and Artificial Respiration Apparatus. Be the first supplier listed.
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Duty Collected |
|---|---|---|---|---|
| 9019200000 | OZONE,OXYGEN,ETC THERAPY, RESPIRATION APPARATUS,PT | $370.1M | 9.84% | $5.9M |
OZONE,OXYGEN,ETC THERAPY, RESPIRATION APPARATUS,PT
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 9019200000 | OZONE,OXYGEN,ETC THERAPY, RESPIRATION APPARATUS,PT | $81.2M |
OZONE,OXYGEN,ETC THERAPY, RESPIRATION APPARATUS,PT
15.4M no
INSTR & APPL F MEDICAL SURGICAL DENTAL VET, NESOI
HS 901890
MED NEEDLES. NESOI, CATHERERS ETC AND PARTS ETC
HS 901839
ARTIFICIAL JOINTS & PARTS & ACCESSORIES THEROF,NES
HS 902139
ELECTRO-DIAGNOSTIC APPARATUS NESOI, AND PARTS ETC.
HS 901819
MEAS CHECKNG INSTRUMENT & MACH, NOT OPTICAL, NESOI
HS 903180
ARTIFICIAL JOINTS AND PARTS AND ACCESSORIES THEROF
HS 902131
| State | Imports | Exports | Balance |
|---|---|---|---|
| California | $114.7M | $16.2M | -$98.5M |
| Georgia | $119.0M | $8.4M | -$110.6M |
| Kentucky | $36.3M | -- | -$36.3M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| LOS ANGELES, CA | $106.4M | $3.7M | -$102.7M |
| SAVANNAH, GA | $88.8M | -- | -$88.8M |
| OTAY MESA, CA | $30.6M | $1.6M | -$29.0M |